Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA.
J Clin Psychiatry. 2012 Jul;73(7):1016-22. doi: 10.4088/JCP.11m07100. Epub 2012 May 15.
The true benefit of pharmacologic intervention to improve cognition in schizophrenia may not be evident without regular cognitive enrichment. Clinical trials assessing the neurocognitive effects of new medications may require engagement in cognitive remediation exercises to stimulate the benefit potential. However, the feasibility of large-scale multisite studies using cognitive remediation at clinical trials sites has not been established.
53 adult patients with DSM-IV schizophrenia from 9 university-affiliated sites were randomized to a cognitive remediation condition that included the Posit Science Brain Fitness auditory training program with weekly Neuropsychological and Educational Approach to Remediation (NEAR) "bridging groups" or a control condition of computer games and weekly healthy lifestyles groups. Patients were expected to complete 3 to 5 one-hour sessions weekly for 40 sessions or 12 weeks, whichever came first. The primary outcomes were feasibility results as measured by rate of enrollment, retention, and completion rate of primary outcome measures. The study was conducted from July 2009 through January 2010.
During a 3-month enrollment period, 53 (of a projected 54) patients were enrolled, and 41 (77%) met criteria for study completion. Thirty-one patients completed all 40 sessions, and all patients completed all primary outcome measures. Preliminary efficacy results indicated that, after 20 sessions, patients in the cognitive remediation condition demonstrated mean MATRICS Consensus Cognitive Battery composite score improvements that were 3.7 (95% CI, 0.05-7.34) T-score points greater than in patients in the computer-games control group (F(1,46) = 4.16, P = .047). At the end of treatment, a trend favoring cognitive remediation was not statistically significant (F(1,47) = 2.26, P = .14).
Multisite clinical trials of cognitive remediation using the Posit Science Brain Fitness auditory training program with the NEAR method of weekly bridging groups at traditional clinical sites appear to be feasible.
ClinicalTrials.gov identifier: NCT00930150.
如果没有定期的认知强化,药物干预改善精神分裂症认知的真正益处可能并不明显。评估新药物神经认知效应的临床试验可能需要进行认知矫正练习,以激发潜在益处。然而,在临床试验现场使用认知矫正进行大规模多中心研究的可行性尚未确定。
来自 9 个大学附属机构的 53 名 DSM-IV 精神分裂症成年患者被随机分配到认知矫正组,该组包括 Posit Science 大脑健身听觉训练计划和每周神经心理学和教育方法进行矫正(NEAR)“桥接小组”,或对照组,包括电脑游戏和每周健康生活方式小组。患者预计每周完成 3 到 5 次 1 小时的治疗,共 40 次或 12 周,以先到者为准。主要结果是通过入组率、保留率和主要结果测量完成率来衡量的可行性结果。该研究于 2009 年 7 月至 2010 年 1 月进行。
在 3 个月的入组期间,共入组 53 名(预计 54 名)患者,41 名(77%)符合研究完成标准。31 名患者完成了所有 40 次治疗,所有患者完成了所有主要结果测量。初步疗效结果表明,在完成 20 次治疗后,认知矫正组患者的 MATRICS 共识认知电池综合评分提高了 3.7(95%CI,0.05-7.34)T 分数点,高于电脑游戏对照组的患者(F(1,46)=4.16,P=0.047)。在治疗结束时,认知矫正的趋势虽有优势但无统计学意义(F(1,47)=2.26,P=0.14)。
在传统临床场所使用 Posit Science 大脑健身听觉训练计划和每周 NEAR 桥接小组方法进行认知矫正的多中心临床试验似乎是可行的。
ClinicalTrials.gov 标识符:NCT00930150。